Paul Hendrie

University of Washington

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Oshrat Hershkovitz‐Rokah

ISRAEL

View details

Matthew Collin

Professor of Haematology

Newcastle University

UNITED KINGDOM

View details

Benjamin Durham

Assistant Professor, Tenure-Track

Rutgers Cancer Institute of New Jersey

UNITED STATES

View details

Michael Hochman

Assistant Professor

Winship Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paul Hendrie

Research Interests

Explore related searches

Contact this professor

Articles (10)

Comparative analysis of infectious complications with outpatient vs. inpatient care for adults with high-risk myeloid neoplasm receiving intensive induction chemotherapy

Comparison of outpatient care following intensive induction versus post-remission chemotherapy for adults with acute myeloid leukemia and other high-grade myeloid neoplasms

Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML)

Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility

Before the Flood

Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm

Erdheim-Chester disease: Consensus recommendations for evaluation, diagnosis, and treatment in the molecular era

Erdheim–Chester disease

Managing Cancer Care during the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal

Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome

Collaborators (4)

Oshrat Hershkovitz‐Rokah

Matthew Collin

Benjamin Durham

Michael Hochman

Make your next move.